Literature DB >> 11685590

Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators.

S Picca1, C Dionisi-Vici, D Abeni, A Pastore, C Rizzo, M Orzalesi, G Sabetta, G Rizzoni, A Bartuli.   

Abstract

We investigated the prognostic indicators in ten hyperammonemic neonates: four treated by continuous arteriovenous hemodialysis (CAVHD), four with continuous venovenous hemodialysis (CVVHD), and two with hemodialysis (HD). Plasma ammonium levels decreased significantly within the first 24 h irrespective of dialysis modality (from 1419 to 114 micromol/l, median values; P<0.0001). CVVHD achieved the highest ammonium clearance. HD provided highest ammonium extraction but clearance was hampered by severe hemodynamic instability. Five patients had a good outcome (normal at follow-up of 9-59 months), five had poor outcome (four died and one has severe neurological damage). Total coma duration was shorter in patients who had a good outcome (47+/-11 vs 78+/-13 h; P=0.02). Remarkably, only coma duration before dialysis determined this difference (22.2+/-10.1 vs 48.8+/-11.2 h; P=0.02). In cases with good outcome, coma duration was <33 h, whereas the others exceeded this limit. The prognosis was not related to dialysis modality, rapidity in reducing ammonium levels or to the underlying metabolic defect. In conclusion, results showed CVVHD to be the optimal modality for extracorporeal ammonium detoxification. However, the most relevant indicator for prognosis was coma duration before the start of dialysis. Therefore, major efforts should be made to refer patients quickly to highly specialized centers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685590     DOI: 10.1007/s004670100702

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  48 in total

1.  Experience of continuous haemodiafiltration in a male neonate with ornithine transcarbamylase deficiency.

Authors:  Shigehiro Enkai; Masaki Yamamoto; Kaori Hayashi; Masaki Kobayashi; Tomohiro Sasajima; Takasuke Amizuka; Wataru Abo
Journal:  Eur J Pediatr       Date:  2003-08-01       Impact factor: 3.183

2.  Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.

Authors:  Timothy E Bunchman; Gina-Marie Barletta; John W Winters; John J Gardner; Teri L Crumb; Kevin D McBryde
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

3.  A biphasic dialytic strategy for the treatment of neonatal hyperammonemia.

Authors:  Mark Hanudel; Sonal Avasare; Eileen Tsai; Ora Yadin; Joshua Zaritsky
Journal:  Pediatr Nephrol       Date:  2014-02       Impact factor: 3.714

Review 4.  Brain imaging in urea cycle disorders.

Authors:  Andrea Gropman
Journal:  Mol Genet Metab       Date:  2010-02-13       Impact factor: 4.797

5.  Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients.

Authors:  Sébastien Lévesque; Marie Lambert; Aspasia Karalis; Serge Melancon; Laura Russell; Nancy Braverman
Journal:  JIMD Rep       Date:  2011-09-06

Review 6.  Dialysis modalities for the management of pediatric acute kidney injury.

Authors:  Lara de Galasso; Stefano Picca; Isabella Guzzo
Journal:  Pediatr Nephrol       Date:  2019-03-18       Impact factor: 3.714

Review 7.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

8.  Efficacy and safety of intermittent hemodialysis in infants and young children with inborn errors of metabolism.

Authors:  I-Jung Tsai; Wuh-Liang Hwu; Shu-Chien Huang; Ni-Chung Lee; En-Ting Wu; Yin-Hsiu Chien; Yong-Kwei Tsau
Journal:  Pediatr Nephrol       Date:  2013-09-08       Impact factor: 3.714

9.  Acute extrapyramidal syndrome in mild ornithine transcarbamylase deficiency: metabolic stroke involving the caudate and putamen without metabolic decompensation.

Authors:  C E Keegan; D M Martin; D J Quint; J L Gorski
Journal:  Eur J Pediatr       Date:  2003-02-07       Impact factor: 3.183

Review 10.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.